
FDA processes over 24,000 product applications in 2025, exceeds annual target
At its 2025 Annual Stakeholders' Meeting in Accra, the Authority reported that 62 per cent of newly registered products were locally manufactured, as it outlined reforms including digitalisation, 60 new district offices and a planned vaccines laboratory built with Germany and the EU.





